Project Details
Description
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ACE-083 in Patients with Charcot- Marie-Tooth Disease Types 1 and X
| Status | Finished |
|---|---|
| Effective start/end date | 2/1/17 → 1/31/21 |
Funding
- ACCELERON PHARMA INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.